Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting.
View all » 
Recent Releases
Nov 15, 2011
Cadence Pharmaceuticals Announces Pricing of Public Offering of Common Stock
View all »Events
Nov 3, 2011 at 1:30 PM PT
Cadence Pharmaceuticals 3rd Quarter 2011 Earnings Release
Sep 28, 2011 at 9:30 AM ET
JMP Securities Healthcare Conference
| Stock Quote |
|---|
| CADX - (NASDAQ)
$4.27 + 0.05 Feb 3, 2012 4:00 PM ET |
Quotes delayed at
least 20 minutes.
Information provided
by eSignal.